SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Apr-20 6:59 PM View: | Avalo Therapeutics, Inc. (CERC) | 09-Apr-20 | Payment of Exercise | 20,901 | $2.57 | $53,715.60 | (8%) 262.73K to 241.83K | (16%) |
29-Aug-19 5:03 PM View: | Avalo Therapeutics, Inc. (CERC) | 27-Aug-19 | Market Purchase | 6,734 | $2.98 | $20,100.30 | 3% 256.0K to 262.73K | (< 1%) |
29-May-19 5:31 PM View: | Avalo Therapeutics, Inc. (CERC) | 24-May-19 | Grant | 250,000 | -- | -- | 4167% 6.0K to 256.0K | |
16-May-19 4:19 PM View: | Avalo Therapeutics, Inc. (CERC) | 14-May-19 | Market Purchase | 6,000 | $5.06 | $30,336.00 | 100% 0 to 6.0K | (41%) |
17-Apr-19 4:19 PM View: | Athenex, Inc. (ATNX) | 16-Apr-19 | Grant | 1,402 | -- | -- | 36% 3.91K to 5.31K | |
14-Nov-18 6:10 PM View: | Athenex, Inc. (ATNX) | 14-Nov-18 | Market Purchase | 2,908 | $10.26 | $29,830.30 | 291% 1.0K to 3.91K | 15% |
22-Aug-14 4:38 PM View: | Cellectar Biosciences, Inc. (CLRB) | 20-Aug-14 | Purchase | 13,300 | $3.75 | $49,875.00 | 100% 0 to 13.3K | |
07-Sep-10 8:22 AM View: | Chelsea Therapeutics Intern... (CHTP) | 02-Sep-10 | Market Purchase | 1,250 | $4.08 | $5,100.00 | < 1% 486.93K to 488.18K | 19% |
21-Dec-09 2:27 PM View: | Chelsea Therapeutics Intern... (CHTP) | 17-Dec-09 | Market Purchase | 4,600 | $2.20 | $10,120.00 | < 1% 482.33K to 486.93K | 120% |
24-Sep-08 4:20 PM View: | Chelsea Therapeutics Intern... (CHTP) | 24-Sep-08 | Market Purchase | 3,000 | $2.91 | $8,717.00 | < 1% 479.33K to 482.33K | 67% |
24-Aug-06 2:54 PM View: | Chelsea Therapeutics Intern... (CHTP) | 23-Aug-06 | Market Purchase | 1,000 | $3.27 | $3,267.00 | < 1% 478.33K to 479.33K | 48% |